S'abonner

Smoking status related to Covid-19 mortality and disease severity in a veteran population - 08/12/21

Doi : 10.1016/j.rmed.2021.106668 
Laura A. Wilkinson a, Kari A. Mergenhagen a, , Michael T. Carter a, Hubert Chua a, Collin Clark b, Bethany A. Wattengel a, John A. Sellick c, d, Ali A. El-Solh e
a Veteran Affairs Western New York Healthcare System, Department of Pharmacy, Buffalo, NY, United States 
b University at Buffalo School of Pharmacy and Pharmaceutical Sciences, United States 
c Veteran Affairs Western New York Healthcare System, Department of Infectious Diseases, Buffalo, NY, United States 
d Jacobs School of Medicine and Biomedical Sciences, Department of Internal Medicine, Buffalo, NY, United States 
e Veteran Affairs Western New York Healthcare System, Department of Research and Development, Buffalo, NY, United States 

Corresponding author. Pharmacy Department, 119, VA Western New York Healthcare System 3495 Bailey Avenue, Buffalo, NY, 14215, United States.Pharmacy Department119, VA Western New York Healthcare System 3495 Bailey AvenueBuffaloNY14215United States

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Abstract

Introduction

Cigarette smoking is associated with development of significant comorbidities. Patients with underlying comorbidities have been found to have worse outcomes associated with Coronavirus Disease 2019 (Covid-19). This study evaluated 30-day mortality in Covid-19 positive patients based on smoking status.

Methods

This retrospective study of veterans nationwide examined Covid-19 positive inpatients between March 2020 and January 2021. Bivariate analysis compared patients based on smoking history. Propensity score matching adjusted for age, gender, race, ethnicity, Charlson comorbidity index (0–5 and 6–19) and dexamethasone use was performed. A multivariable logistic regression with backwards elimination and Cox Proportional Hazards Ratio was utilized to determine odds of 30-day mortality.

Results

The study cohort consisted of 25,958 unique Covid-19 positive inpatients. There was a total of 2,995 current smokers, 12,169 former smokers, and 8,392 non-smokers. Death was experienced by 13.5% (n = 3503) of the cohort within 30 days. Former smokers (OR 1.15; 95% CI, 1.05–1.27) (HR 1.13; 95% CI, 1.03–1.23) had higher risk of 30-day mortality compared with non-smokers. Former smokers had a higher risk of death compared to current smokers (HR 1.16 95% CI 1.02–1.33). The odds of death for current vs. non-smokers did not significantly differ.

Conclusion

Compared to veteran non-smokers with Covid-19, former, but not current smokers with Covid-19 had a significantly higher risk of 30-day mortality.

Le texte complet de cet article est disponible en PDF.

Highlights

Former smokers have increased 30-day mortality post COVID compared to non-smokers.
Age and comorbidities also impact mortality in patients with COVID-19.
There was no significant difference in mortality between current and non-smokers.

Le texte complet de cet article est disponible en PDF.

Keywords : Covid-19, Coronavirus, Smoking, Veterans, Infectious disease


Plan


 All authors have no conflicts of interest to disclose. This material is the result of work supported with resources and the use of facilities at the Veterans Affairs Western New York Healthcare System. The contents of this manuscript are not intended to represent the views of the Department of Veterans Affairs or the United States government.


© 2021  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 190

Article 106668- décembre 2021 Retour au numéro
Article suivant Article suivant
  • Respiratory muscle training program supplemented by a cell-phone application in COPD patients with severe airflow limitation
  • Barata Paula Irina, Marc Monica Steluta, Tudorache Emanuela, Manolescu Diana, Olar Dana Cristina, Frandes Mirela, Oancea Cristian

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.